PROTEOMICS OF TEAR IN INACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY

被引:0
|
作者
Jiang, L. [1 ]
Wei, R. [1 ]
Diao, J. [1 ]
Ding, H. [1 ]
Wang, W. [1 ]
Ao, R. [1 ]
机构
[1] Tongji Univ, Tongji Hosp, Sch Med, Dept Ophthalmol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Tear proteomics; Thyroid-associated ophthalmopathy; Inactive stage; Bioinformatics; GRAVES OPHTHALMOPATHY; HORMONE; ORBITOPATHY; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Thyroid-associated ophthalmopathy (TAO), one of the most common orbital diseases in adults, seriously reduces patients' quality of life. Although human tear proteomics identified many abnormal expressed proteins and proposed several pathogeneses of TAO, most of these studies focused on the active stage or mixed types in TAO. In this study we identified significantly changed proteins and preliminary revealed the potential signalling pathways and mechanisms of TAO with the late, inactive stage. Patients and Methods. Tears from TAO patients (n=6) with a CAS score < 3 and 6 control healthy subject were collected. The pooled tears were further fractionated using high pH reversed-phase chromatography, then submitted to LC-MS/MS and subsequent bioinformatic analysis. Results. Proteomic profiling identified 107 significantly changed proteins between the inactive stage of TAO patients and healthy cases. Among these proteins, 62 were upregulated, and 45 were downregulated in TAO cases compared to healthy individuals. Enrichment analysis revealed that the immune system, cell cycle, metabolism (carbohydrate metabolism and metabolism of cofactors and vitamins), protein synthesis and degradation might play a vital role in the progress of inactive TAO. The present investigation represents the first proteomic tear study of TAO patients in the inactive stage. Conclusion. The results shed light on the differences between inactive TAO patients and healthy cases, thus enabling us to understand better the molecular mechanisms and potential targets for the treatment of inactive TAO.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Tear proteomics of orbital decompression for disfiguring exophthalmos in inactive thyroid-associated ophthalmopathy
    Jiang, Lihong
    Rong, Ao
    Wei, Ruili
    Diao, Jiale
    Ding, Hui
    Wang, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (06)
  • [2] Choroidal profile in patients with inactive thyroid-associated ophthalmopathy
    Mahsan Samadi
    Hamidreza Ghanbari
    Ali Momeni
    Elias Khalili Pour
    Ali Banafsheh Afshan
    Nima Naghshtabrizi
    Seyed Mohsen Rafizadeh
    Hamid Riazi Esfahani
    BMC Ophthalmology, 25 (1)
  • [3] Proteomics of Tear Fluid in Thyroid-Associated Orbitopathy
    Matheis, Nina
    Okrojek, Rainer
    Grus, Franz H.
    Kahaly, George J.
    THYROID, 2012, 22 (10) : 1039 - 1045
  • [4] Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy
    Higashiyama, Tomoaki
    Ohji, Masahito
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 2415 - 2421
  • [5] THYROID-ASSOCIATED OPHTHALMOPATHY
    WEETMAN, AP
    AUTOIMMUNITY, 1992, 12 (03) : 215 - 222
  • [6] Changes of Lacrimal Gland and Tear Inflammatory Cytokines in Thyroid-Associated Ophthalmopathy
    Huang, Danping
    Luo, Quan
    Yang, Huasheng
    Mao, Yuxiang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (08) : 4935 - 4943
  • [7] SINUSITIS IN THYROID-ASSOCIATED OPHTHALMOPATHY
    DAVRIS, S
    RIECHELMANN, H
    MANN, W
    KAHALY, G
    AMERICAN JOURNAL OF RHINOLOGY, 1993, 7 (05): : 233 - 235
  • [8] Progress in thyroid-associated ophthalmopathy
    Hiromatsu, Y
    Wall, JR
    THYROID, 2002, 12 (03) : 185 - 185
  • [9] Rituximab for thyroid-associated ophthalmopathy
    Minakaran, Neda
    Ezra, Daniel G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [10] PATHOGENESIS OF THYROID-ASSOCIATED OPHTHALMOPATHY
    PERROS, P
    KENDALLTAYLOR, P
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1993, 4 (08): : 270 - 275